| |
| |
|
| Insider
Information: |
Clancy Paul J |
| Relationship: |
Director |
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
5 |
|
| Direct
Shares |
138,295 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$20,757,220 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
138,295 |
|
|
| Total
Value |
$20,757,220 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Biogen Idec Inc |
BIIB |
Executive VP and CFO |
2017-04-25 |
10,813 |
|
0 |
Premium* |
|
|
Alexion Pharmaceuticals Inc |
ALXN |
EVP, Chief Financial O... |
2019-07-11 |
90,447 |
2017-07-10 |
0 |
Premium* |
|
|
Incyte Corp |
INCY |
Director |
2024-03-28 |
15,785 |
2019-03-29 |
0 |
Premium* |
|
|
Agios Pharmaceuticals Inc |
AGIO |
Director |
2022-05-20 |
6,549 |
2019-05-31 |
0 |
Premium* |
|
|
Exact Sciences Corp |
EXAS |
Director |
2023-06-08 |
14,701 |
2021-03-18 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
119 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 5
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ALXN |
Alexion Pharmaceuticals I... |
EVP, Chief Financial Officer |
• – – |
2019-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
9,428 |
95,677 |
0 |
- |
|
| INCY |
Incyte Corp |
Director |
– • – |
2019-04-26 |
4 |
A |
$0.00 |
$0 |
D/D |
1,520 |
1,723 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Director |
– • – |
2019-05-31 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,400 |
1,400 |
0 |
- |
|
| INCY |
Incyte Corp |
Director |
– • – |
2020-05-26 |
4 |
A |
$0.00 |
$0 |
D/D |
1,282 |
4,026 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Director |
– • – |
2020-05-29 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,878 |
3,278 |
0 |
- |
|
| EXAS |
Exact Sciences Corp |
Director |
– • – |
2021-03-18 |
4 |
A |
$0.00 |
$0 |
D/D |
2,929 |
2,929 |
0 |
- |
|
| INCY |
Incyte Corp |
Director |
– • – |
2021-05-26 |
4 |
A |
$0.00 |
$0 |
D/D |
1,923 |
7,017 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Director |
– • – |
2021-05-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,686 |
4,964 |
0 |
- |
|
| EXAS |
Exact Sciences Corp |
Director |
– • – |
2021-06-30 |
4 |
A |
$0.00 |
$0 |
D/D |
2,567 |
5,496 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Director |
– • – |
2022-05-20 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,585 |
6,549 |
0 |
- |
|
| EXAS |
Exact Sciences Corp |
Director |
– • – |
2022-06-09 |
4 |
A |
$0.00 |
$0 |
D/D |
5,606 |
11,102 |
0 |
- |
|
| INCY |
Incyte Corp |
Director |
– • – |
2022-06-15 |
4 |
A |
$0.00 |
$0 |
D/D |
2,144 |
10,434 |
0 |
- |
|
| EXAS |
Exact Sciences Corp |
Director |
– • – |
2023-06-08 |
4 |
A |
$0.00 |
$0 |
D/D |
3,599 |
14,701 |
0 |
- |
|
| INCY |
Incyte Corp |
Director |
– • – |
2023-06-14 |
4 |
A |
$0.00 |
$0 |
D/D |
2,505 |
14,211 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Executive VP and CFO |
• – – |
2011-04-28 |
4 |
OE |
$37.45 |
$608,119 |
D/D |
14,766 |
51,958 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Executive VP and CFO |
• • – |
2013-09-16 |
4 |
OE |
$41.03 |
$5,556,895 |
D/D |
99,030 |
51,027 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Executive VP and CFO |
• – – |
2012-02-01 |
4 |
OE |
$43.50 |
$1,133,088 |
D/D |
21,400 |
42,568 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Executive VP and CFO |
• – – |
2010-06-01 |
4 |
D |
$47.22 |
$59,167 |
D/D |
(1,253) |
47,732 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Executive VP and CFO |
• – – |
2009-08-01 |
4 |
D |
$47.55 |
$56,252 |
D/D |
(1,183) |
44,705 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Executive VP and CFO |
• – – |
2008-09-04 |
4 |
D |
$48.16 |
$53,650 |
D/D |
(1,114) |
41,555 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Executive VP and CFO |
• • – |
2013-09-18 |
4 |
OE |
$49.65 |
$1,329,875 |
D/D |
26,785 |
33,872 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Executive VP and CFO |
• – – |
2008-09-19 |
4 |
AS |
$50.00 |
$77,650 |
D/D |
(1,553) |
40,002 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
CFO |
• – – |
2008-08-01 |
4 |
D |
$50.01 |
$13,253 |
D/D |
(265) |
37,237 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Executive VP and CFO |
• – – |
2008-08-08 |
4 |
AS |
$50.66 |
$28,777 |
D/D |
(568) |
42,669 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Executive VP and CFO |
• – – |
2009-06-01 |
4 |
D |
$50.90 |
$63,778 |
D/D |
(1,253) |
45,888 |
0 |
- |
|
119 Records found
|
|
Page 2 of 5 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
